Pharmafile Logo
Pharmafocus logo
Advanced Search

Neurology

Showing 15 posts of 109 posts found.

NeuroSense shares update from ALS treatment trial

July 2, 2024
Research and Development NeuroSense, Neurology, als, clinical trial

NeuroSense has announced new statistically significant results from the 12-month analysis of its PARADIGM phase 2b study which assessed PrimeC …

News

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024
Research and Development MS, Neurology, Sanofi, multiple sclerosis

Sanofi has announced new phase 2 trial data for its CD40L monoclonal antibody, frexalimab, for the treatment of patients with …

News
robina-weermeijer-so1l3jsdd3y-unsplash_2

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024
Business Services Alzheimers, Biogen, Eisai, Leqembi, Neurology, lecanemab

Eisai and Biogen have announced that Leqembi (lecanemab) has been launched in China as a treatment for mild cognitive impairment …

News
max-bender-w5bn80xghre-unsplash_1

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024
Research and Development AskBio, Neurology, Parkinson's disease, clinical trial

Asklepios BioPharmaceutical (AskBio), a subsidiary of Bayer, has announced that it has initiated the recruitment for its phase 2 REGENERATE-PD …

News

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024
Research and Development CIDP, Hyqvia, Neurology, Takeda, clinical trial

Takeda has announced data from the phase 3 ADVANCE-CIDP 3 trial, which assessed the safety and efficacy of Hyqvia (Immune …

News

Cara Therapeutics shares data from part a of notalgia paresthetica trial

June 13, 2024
Research and Development Cara Therapeutics, Neurology, clinical trial, notalgia paresthetica, pruritus

Cara Therapeutics has announced the outcome from the dose-finding Part A of the KOURAGE-1 study which assessed the efficacy and …

News

Evotec shares progress in Bristol Myers Squibb neuroscience collaboration

June 12, 2024
Research and Development Evotec, Neurology, bristol myers squibb, neuroscience

Evotec has announced that it has reached important scientific progress within the neuroscience collaboration with Bristol Myers Squibb, initiating a …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

FDA accepts Eisai’s Leqembi sBLA for early AD treatment

June 11, 2024
Medical Communications Alzheimer's, Biogen, FDA, Neurology, sBLA

Eisai and Biogen have announced that the US Food and Drug Administration (FDA) has accepted Eisai’s supplemental biologics license application …

News

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024
Research and Development NeuroSense, Neurology, als, clinical trials

NeuroSense has announced that it has partnered with PhaseV for its upcoming phase 3 trial of PrimeC as a treatment …

News
dementia image

Nxera Pharma partner Neurocrine Biosciences enters phase 1 NBI-1117567 study

May 9, 2024
Research and Development Alzheimer's disease, Neurocrine Biosciences, Neurology, Nxera Pharma, Parkinson's disease, clinical trials, dementia, schizophrenia

Nxera Pharma’s neuroscience-focused biopharmaceutical partner  Neurocrine Biosciences has announced it has successfully started its phase 1, first-in-human trial of investigational …

News
trials

Broken String Biosciences and the Francis Crick Institute collaborate on ALS research

May 7, 2024
Research and Development Broken String Biosciences, Francis Crick Institute, Neurology, amyotrophic lateral sclerosis, genomics

Genomics company Broken String Biosciences and biomedical discovery institute Francis Crick have announced a research collaboration, focusing on amyotrophic lateral …

News
robina-weermeijer-ihfopazzjhm-unsplash_5

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024
Research and Development Kaerus Bioscience, Neurolentech, Neurology, neurodevelopmental disorders, neurology

Neurolentech has announced that it has entered into a technology access partnership with Kaerus Bioscience, with the aim of driving …

News

Intra-Cellular Therapies shares phase 3 results for major depressive disorder therapy

April 17, 2024
Research and Development Intra-Cellular Therapies, Neurology, clinical trial, major depressive disorder, mental health

Intra-Cellular Therapies has announced positive topline results from Study 501, which assessed lumateperone 42mg as an adjunctive therapy to antidepressants …

News

NICE recommends migraine treatment for NHS use

April 11, 2024
Medical Communications NHS, NICE, Neurology, migraine

The National Institute for Health and Care Excellence (NICE) has shared draft guidance recommending AbbVie’s Aquipta (atogepant) as an option …

News

PureTech Health launches Seaport Therapeutics

April 9, 2024
Business Services Financing, Neurology, PureTech Health, launch

PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to patients and unlock value for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025